FC
BMRA icon

Fore Capital’s Biomerica BMRA Stock Holding History

Fore Capital’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,460
Closed -$19.6K – 52
2024
Q3 		$19.6K Hold
7,460
– – 0.01% 41
2024
Q2 		$26.2K Hold
7,460
– – 0.02% 50
2024
Q1 		$49.7K Buy
7,460
+3,125
+72% +$25.4K 0.03% 46
2023
Q4 		$43.4K Buy
4,335
+1,875
+76% +$14.2K 0.02% 36
2023
Q3 		$16.9K Sell
2,460
-125
-5% -$1.24K 0.01% 31
2023
Q2 		$28.1K Sell
2,585
-3,625
-58% -$42.9K 0.01% 27
2023
Q1 		$92.9K Buy
6,210
+2,500
+67% +$53.9K 0.05% 23
2022
Q4 		$99.4K Sell
3,710
-2,750
-43% -$79K 0.04% 35
2022
Q3 		$203K Sell
6,460
-4,165
-39% -$108K 0.25% 23
2022
Q2 		$246K Hold
10,625
– – 0.26% 27
2022
Q1 		$380K Hold
10,625
– – 0.18% 39
2021
Q4 		$331K Sell
10,625
-6,250
-37% -$241K 0.11% 43
2021
Q3 		$608K Hold
16,875
– – 0.31% 40
2021
Q2 		$541K Buy
16,875
+7,232
+75% +$245K 0.16% 52
2021
Q1 		$421K Buy
+9,643
New +$494K 0.08% 55

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fore Capital's BMRA Position: Q4 2024 in Review

Fore Capital sold out of Biomerica (BMRA) in Q4 2024, closing a stake of 7,460 shares — an estimated $19.6K sold.

Fore Capital first reported a position in BMRA in Q1 2021 and held it in 15 quarters. The position peaked at $608K in Q3 2021. 21 funds tracked by Wall St. Rank hold BMRA as of Q4 2024.

  • Fore Capital reported no remaining Biomerica position as of Q4 2024 after selling out during the quarter.
  • Fore Capital sold 7,460 Biomerica shares in Q4 2024, an estimated $19.6K.
  • Fore Capital first reported a position in Biomerica in Q1 2021 and held it in 15 quarters.
  • Fore Capital's Biomerica position peaked at $608K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Biomerica as of Q4 2024.

Based on Fore Capital's 13F filing for Q4 2024, filed 10 Feb 2025.